Biomarkers in pancreatic adenocarcinoma: current perspectives - Test2 - elhamkhani - TriplyDB

Biomarkers in pancreatic adenocarcinoma: current perspectives

Biomarkers in pancreatic adenocarcinoma: current perspectives

http://www.wikidata.org/entity/Q28072309

about

ImmunoPET imaging of tissue factor expression in pancreatic cancer with 89Zr-Df-ALT-836.Challenges and Opportunities in Modeling Pancreatic Cancer.Silencing the roadblocks to effective triple-negative breast cancer treatments by siRNA nanoparticles.SERP1 is a novel marker of poor prognosis in pancreatic ductal adenocarcinoma patients via anti-apoptosis and regulating SRPRB/NF-κB axis Metabolomic biomarkers of pancreatic cancer: a meta-analysis study.Significance of combined preoperative serum Alb and dNLR for diagnosis of pancreatic cancer.Identification of Prognostic Biomarkers by Combined mRNA and miRNA Expression Microarray Analysis in Pancreatic Cancer.Prognostic value of glypican-1 for patients with advanced pancreatic cancer following regional intra-arterial chemotherapy.A combined computational-experimental approach to define the structural origin of antibody recognition of sialyl-Tn, a tumor-associated carbohydrate antigen

P2860

Q38607046-BFAAA98A-E003-45E5-8D14-8F82F13158D2 Q38746419-441835D0-1AB4-48FE-B2F5-2ECD39AA016F Q39113994-4F17455D-03E6-404B-A844-1A7A0B9D7788 Q41389748-82B69794-F27E-4F40-AE97-E95BCDCCB277 Q42154484-61A43870-F053-44C1-AC62-609E5C9BEF3B Q47729729-0A58577F-C6B1-4FBB-A1BE-0E2BE598F9E6 Q52431407-0A77181C-A748-45BA-BAEA-077FC095AF7F Q55357613-973B206D-96DF-48F8-83C2-467AA1F33851 Q58061110-80510803-41FD-42D8-8763-D441BD94E07E

P2860

Biomarkers in pancreatic adenocarcinoma: current perspectives

http://www.wikidata.org/entity/Q28072309

description

2016 nî lūn-bûn

@nan

2016 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Biomarkers in pancreatic adenocarcinoma: current perspectives

@ast

Biomarkers in pancreatic adenocarcinoma: current perspectives

@en

Biomarkers in pancreatic adenocarcinoma: current perspectives

@nl

type

label

Biomarkers in pancreatic adenocarcinoma: current perspectives

@ast

Biomarkers in pancreatic adenocarcinoma: current perspectives

@en

Biomarkers in pancreatic adenocarcinoma: current perspectives

@nl

prefLabel

Biomarkers in pancreatic adenocarcinoma: current perspectives

@ast

Biomarkers in pancreatic adenocarcinoma: current perspectives

@en

Biomarkers in pancreatic adenocarcinoma: current perspectives

@nl

P1433

Q28072309-39004594-C65D-42D4-84A5-9C44AA2860B4

P1476

Q28072309-41D09AC6-4C62-4AAB-B473-F87315D17688

P2093

Q28072309-3CC22574-485A-4307-A04F-B3B4B8D3C020

Q28072309-43B1423A-83BC-43D2-97D8-2512B6A60F36

Q28072309-64051C81-6B05-478E-81CF-9715F0F6C0C4

Q28072309-F867423A-5FA4-45EE-8323-CFA35B54E7C4

P2860

Q28072309-03869259-E451-4CC0-9FBA-FAA808B8AC90

Q28072309-07EA515C-F89E-4B1B-81E0-41ED4C6DEA77

Q28072309-0942BF05-D747-45CE-A519-0C23B2265ED6

Q28072309-0B019A27-CD1A-4931-B851-3245F1B4BE00

Q28072309-0BB313B1-1FFA-4138-902E-9AE3CA381E3E

Q28072309-168D80C0-7A84-425C-AE20-794E54256FA5

Q28072309-1821539A-E59C-452C-9EA2-0682A093B71D

Q28072309-1F348BAA-62C4-4023-88CA-67FB3E63D352

Q28072309-1F6DA16F-81B0-4FF1-AE53-4A1322D76B19

Q28072309-1F9BA6DE-AA9B-44EC-8A0A-4D0E62C9CA89

P304

Q28072309-D65DD4A0-2E0C-42CC-8064-DC9A33637003

P31

Q28072309-A6EDE634-BCAC-4526-A62C-7C05FA31AF90

P356

Q28072309-BBDB37BC-9CE8-4BFA-AEE2-847A20701885

P407

Q28072309-65FC83FF-1B3F-45DA-AA37-A123AB874995

P478

Q28072309-CF1E505E-C4FD-410A-9FF2-0459F1423B50

P577

Q28072309-57820517-21C9-4782-AE64-D9C0458A90C7

P698

Q28072309-4C3319A4-090E-4CFC-98E2-72C9D354A5AC

P921

Q28072309-0AB63EC4-C79F-4ECE-A9D0-7A4E8E653EE0

Q28072309-69EB4F19-FFE5-4C8F-96EB-2FCB2561F7CE

P932

Q28072309-97DFEC6A-E632-45EF-B61E-E24300C2E155

P356

P1433

OncoTargets and Therapy

P1476

Biomarkers in pancreatic adenocarcinoma: current perspectives

@en

P2093

Courtney Scaife

http://www.w3.org/2001/XMLSchema#string

Douglas Swords

http://www.w3.org/2001/XMLSchema#string

Matthew Firpo

http://www.w3.org/2001/XMLSchema#string

Sean Mulvihill

http://www.w3.org/2001/XMLSchema#string

P2860

Isolation of rare circulating tumour cells in cancer patients by microchip technology

Systematic review of peri-operative prognostic biomarkers in pancreatic ductal adenocarcinoma

Improving pancreatic cancer diagnosis using circulating tumor cells: prospects for staging and single-cell analysis

The clinical utility of CA 19-9 in pancreatic adenocarcinoma: diagnostic and prognostic updates

Liquid biopsies: genotyping circulating tumor DNA

Cancer statistics, 2015

Oncomirs - microRNAs with a role in cancer

MicroRNAs: genomics, biogenesis, mechanism, and function

Human equilibrative nucleoside transporter 1 levels predict response to gemcitabine in patients with pancreatic cancer.

Specific antigen in serum of patients with colon carcinoma

P304

7459-7467

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/OTT.S100510

http://www.w3.org/2001/XMLSchema#string

P407

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2016-12-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28003762

http://www.w3.org/2001/XMLSchema#string

P921

P932

5158171

http://www.w3.org/2001/XMLSchema#string